IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Marksans Pharma LTD INR 1.0

CUSIP: Y57686100 | 1 institutional holders

Quarters

Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

Stanley-Laman Group, Ltd.599,100
0.0% of portfolio›$230
StyleTurnoverLocationFiled
Stanley-Laman Group, Ltd.
599,100$2300.0%CoreMediumBerwyn, PA2018-08-09